Security key
G39342103
Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share (CORBF)
CUSIP: G39342103
Q1 2022 13F Holders as of 31 Mar 2022
- Type / Class
- Equity / Ordinary Shares, par value $0.0001 per share
- Shares outstanding
- 133,765,508
- Total 13F shares
- 11,049,025
- Share change
- +280,811
- Total reported value
- $42,536,000
- Put/Call ratio
- 60%
- Price per share
- $3.85
- Number of holders
- 25
- Value change
- +$980,387
- Number of buys
- 14
- Number of sells
- 10
Report period
Q1 2022
Institutions
25
Top holders
10
CORBF full security history
Newer quarter: Q2 2022
Previous quarter: Q4 2021
Global Cord Blood Corp SEC filings
Broader feeds
Reporting periods
Holder history for CUSIP G39342103
Recent filing periods:
Top shareholders of CORBF - Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Oasis Management Co Ltd. |
13F
|
Company |
2.2%
|
2,905,570
|
$12,174,000 | — | 31 Dec 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2.2%
|
2,888,189
|
$12,102,000 | — | 31 Dec 2021 | |
| Man Group plc |
13F
|
Company |
1.3%
|
1,710,042
|
$7,165,000 | — | 31 Dec 2021 | |
| BlueCrest Capital Management Ltd |
13F
|
Company |
1.1%
|
1,452,603
|
$6,086,000 | — | 31 Dec 2021 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.34%
|
448,755
|
$1,880,000 | — | 31 Dec 2021 | |
| Quinn Opportunity Partners LLC |
13F
|
Company |
0.24%
|
324,494
|
$1,360,000 | — | 31 Dec 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.17%
|
221,265
|
$927,000 | — | 31 Dec 2021 | |
| NATIXIS ADVISORS, LLC |
13F
|
Company |
0.13%
|
177,621
|
$744,000 | — | 31 Dec 2021 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.11%
|
146,954
|
$616,000 | — | 31 Dec 2021 | |
| Two Seas Capital LP |
13F
|
Company |
0.09%
|
123,800
|
$519,000 | — | 31 Dec 2021 | |
| Verition Fund Management LLC |
13F
|
Company |
0.06%
|
84,017
|
$352,000 | — | 31 Dec 2021 | |
| Rockefeller Capital Management L.P. |
13F
|
Company |
0.06%
|
79,080
|
$331,000 | — | 31 Dec 2021 | |
| DGS Capital Management, LLC |
13F
|
Company |
0.03%
|
34,446
|
$144,000 | — | 31 Dec 2021 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.02%
|
33,309
|
$140,000 | — | 31 Dec 2021 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.02%
|
32,452
|
$136,000 | — | 31 Dec 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.02%
|
29,704
|
$124,000 | — | 31 Dec 2021 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.02%
|
20,591
|
$86,000 | — | 31 Dec 2021 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.01%
|
14,051
|
$58,000 | — | 31 Dec 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.01%
|
13,400
|
$56,000 | — | 31 Dec 2021 | |
| MONETA GROUP INVESTMENT ADVISORS LLC |
13F
|
Company |
0.01%
|
10,024
|
$42,000 | — | 31 Dec 2021 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.01%
|
6,929
|
$29,000 | — | 31 Dec 2021 | |
| UMB Bank, n.a. |
13F
|
Company |
0%
|
3,978
|
$17,000 | — | 31 Dec 2021 | |
| Steward Partners Investment Advisory, LLC |
13F
|
Company |
0%
|
3,389
|
$14,000 | — | 31 Dec 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
2,331
|
$10,000 | — | 31 Dec 2021 | |
| ISZO CAPITAL MANAGEMENT LP |
13F
|
Company |
0%
|
1,000
|
$4,000 | — | 31 Dec 2021 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
416
|
$2,000 | — | 31 Dec 2021 | |
| Operose Advisors LLC |
13F
|
Company |
0%
|
200
|
$1,000 | — | 31 Dec 2021 |
Institutional Holders of Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share (CORBF) as of Q1 2022
As of 31 Mar 2022,
Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share (CORBF) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,049,025 shares.
The largest 10 holders included
Oasis Management Co Ltd., RENAISSANCE TECHNOLOGIES LLC, Man Group plc, BlueCrest Capital Management Ltd, Qube Research & Technologies Ltd, Quinn Opportunity Partners LLC, BANK OF AMERICA CORP /DE/, NATIXIS ADVISORS, L.P., Parametric Portfolio Associates LLC, and ARROWSTREET CAPITAL, LIMITED PARTNERSHIP.
This page lists
25
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2022 vs Q4 2021 Across Filers
Q4 2021 holders
27
Q1 2022 holders
25
Holder diff
-2
| Investor | Q4 2021 Shares | Q1 2022 Shares | Share Diff | Share Chg % | Q4 2021 Value $ | Q1 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.